<DOC>
	<DOCNO>NCT01519752</DOCNO>
	<brief_summary>The objective study demonstrate Oxiconazole nitrate 1 % topical cream effective treatment patient moderate severe Tinea pedis .</brief_summary>
	<brief_title>A Therapeutic Equivalence Study Two Oxiconazole Nitrate Topical Cream Treatments Patients With Tinea Pedis</brief_title>
	<detailed_description />
	<mesh_term>Tinea</mesh_term>
	<mesh_term>Tinea Pedis</mesh_term>
	<mesh_term>Oxiconazole</mesh_term>
	<criteria>1 . Male nonpregnant , nonlactating female , 12 year age old . 2 . Signed informed consent form , meet criteria current FDA regulation 3 . If female child bear potential , prepare abstain sexual intercourse use reliable method contraception study { e.g. , condom , IUD , oral , transdermal , injected implant hormonal contraceptive ) ( must use product least 30 day prior study start use product throughout duration study ) , transdermal implant hormonal contraceptive } 4 . A confirmed clinical diagnosis tinea pedis lesion localize interdigital space predominantly interdigital , may extend area foot . ( noninterdigital lesion hyperkeratotic i.e. , characteristic moccasin ) . 5 . The presence tinea pedis infection , confirm observation segment fungal hypha microscopic KOH wet mount examination . 1 . Females pregnant , lactate likely become pregnant study . 2 . Any known hypersensitivity oxiconazole nitrate antifungal agent . 3 . Patients past history tinea pedis infection lack response antifungal therapy ( i.e . recurrent tinea pedis , 3 infection past 12 month , unresponsive previous antifungal therapy ) . 4 . Participation research study past 30 day prior screening/randomization .</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2014</verification_date>
	<keyword>Tinea Pedis</keyword>
</DOC>